Bavarian Nordic (OTCPK:BVNRY) has received FDA approval for its vaccine Vimkunya for the prevention of chikungunya. The virus-like particle, or VLP, vaccine is approved for people aged 12 and older.

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...

The Ministry of Public Health (MSP) highlighted its ongoing efforts to prevent, control, and eliminate tropical diseases such ...

The Médecins Sans Frontières (MSF) has called on the Federal Government to prioritise noma disease and ensure that efforts ...

The number of people diagnosed with tropical diseases after travelling abroad has risen significantly with international travel back to pre-pandemic levels. New figures show 89 cases of malaria were ...

In the interconnected web of nature, small disruptions can yield outsized consequences. One such example comes from Central ...

Two people have died from a deadly soil-borne bacteria with authorities reporting higher-than-average rates in 2025 following ...

The prevention and controlling of Neglected Tropical Diseases (NTD) are crucial to ending extreme poverty in the country in the next two decades, the Volta Regional Director of Health, Dr Chrysantus ...

Leishmaniasis is a life-threatening parasitic infection and one of the most concerning neglected vector-borne tropical diseases worldwide. Current leishmaniasis chemotherapeuticals are poorly ...

In the field of global health, climate change poses a severe and multifaceted challenge. The World Health Organization ...